USA – To meet rising demand, GlaxoSmithKline and partner Vir Biotechnology are increasing output of their COVID-19 antibody treatment sotrovimab at a second plant. The supply crunch is exacerbated further…
Read MoreDemand surge for Covid-19 antibody prompts GSK, Vir to ramp up output
